Wanbury share news, announcements and annual reports
NSE: WANBURYBSE: 524212Pharmaceuticals & BiotechnologySmall Cap
Wanbury Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1992 on BSE, Jan 2007 on NSE
Last close ₹189.21up ₹7.28 (4.00%)BSE ₹189.75
Share price at the NSE close on 30 Oct 2026. Previous close ₹181.93.
30 Oct: open ₹180.00, high ₹192.00, low ₹175.98
52-week range of traded prices to 30 Oct 2026
₹161.50Low, 27 Jan 2026₹358.85High, 15 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹662 Cr1,555th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 11.84
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.58
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 54.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 23.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.49
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,32,73737.4% delivered
Wanbury board meetings
160 filed, newest first. Page 4 of 4.
Oct 2007
23 Oct · Board meeting
Meeting on 31 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Sep 2007
28 Sep · Board meeting
Board of Directors of the Company at its meeting held on September 27, 2007 have approved inter alia the following: (1) The cost audit report for the financial year 2006-2007. (2) The sitting fees to be paid to the non-executive directors for attending the Board Meeting and Committee Meetings. (3) The appointment of and remuneration to be paid to Mr. K. R. N. Moorthy as Deputy Managing Director of the Company w.e.f. October 01, 2007. (4) Taking the approval of the shareholders of the Company through Postal Ballot for the appointment of and remuneration to be paid to Mr. K. R. N. Moorthy as Deputy Managing Director of the Company w.e.f October 01, 2007. (5) The remuneration to be paid to Mr. K. Chandran as Whole-time Director of the Company w.e.f. September 01, 2007.20 Sep · Board meeting
Inter alia, to consider the following : 1) The Cost Audit Report for the financial year 2006-2007. 2) The sitting fees to be paid to the non-executive directors for attending the Board Meeting and Committee Meetings. 3) The appointment of and remuneration to be paid to Mr. K. R. N. Moorthy as Dy. Managing Director of the Company. 4) Taking the approval of the shareholders of the Company through Postal Ballot for the appointment of and remuneration to be paid to Mr. K. R. N. Moorthy as Dy. Managing Director of the Company.
Jul 2007
24 Jul · Board meeting
Meeting on 30 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Jun 2007
25 Jun · Board meeting
Interalia, to consider the following : 1) To recommend dividend for the financial year 2006-2007. 2) To approve Annual Accounts for the year ended as on March 31, 2007. 3) To approve date and notice of Annual General Meeting.
May 2007
29 May · Board meeting
Board Members at their meeting held on May 28, 2007, in addition to regular matters, have approved the following: (1) Appointment of Mr. Hemant V. Shah as Cost Auditor of the Company for the Financial Year 2007-2008. (2) Delegation of authority to the Day to Day Affairs Committee to finalize Subscription Agreement and Debenture Trust Deed for Issuance and allotment of Non Convertible Debentures and Optionally Fully Convertible Debentures to be issued to the Banks and Financial Institutions of the Pharmaceutical Products of India Limited (PPIL) and to execute the same. (3) Delegation of authority to the Day to Day Affairs Committee for issuance and allotment of below-mentioned instruments, as per the Order of the Hon ble High Court of Judicature at Bombay dated February 13, 2006 in the matter of the Scheme of Arrangement between the Pharmaceutical Products of India Limited (PPIL) its Secured Creditors and Wanbury Limited and also as per the Order of the Hon ble Board for Industrial and Financial Reconstruction (BIFR) dated May 1, 2007 in the matter of the Pharmaceutical Products of India Limited: (a) Equity Shares of the Company. (b) Non Convertible Debentures; and (c) Optionally Fully Convertible Debentures, (4) Delegation of authority to the Day to Day Affairs committee for issuance and allotment of Equity Shares to the Equity Shareholders of Doctors Organic Chemicals Limited (DOCL) as per the Order of the Hon ble Board for Industrial and Financial Reconstruction (BIFR) dated May 4, 2007 in the matter of Doctors Organic Chemicals Limited. (5) Delegation of authority to the Whole-time Directors of the Company for making investments upto Rs. 10 Crores (Rupees Ten Crores Only)".23 May · Board meeting
In addition to the regular matters below mentioned matter will also be discussed in the Board Meeting: (1) To consider and approve the appointment of Cost Auditor for the Financial Year 2007-2008. (2) To take a note of BIFR Order in the matter of merger of the Pharmaceutical Products of India Limited with the Company. (3) To take a note of BIFR Order in the matter of merger of Doctors Organic Chemicals Limited with the Company.
Mar 2007
14 Mar · Board meeting
The members of the Board of Directors at the adjourned board meeting held on Wednesday the 14th day of March 2007 at 11:30 A.M., approved the following: (1) Draft of Offering Circular, Subscription Agreement, Agency Agreement, Trust Deed, Subscription Letter, Form of Global Certificate & Directors Responsibility Letters for proposed Foreign Currency Convertible Bonds (FCCBs) Issue. (2) Delegation of authority to Day to Day Affairs Committee of the Company (a) to allot Foreign Currency Convertible Bonds (FCCBs) upto Euro 20 Million (b) to issue and allot Equity Shares of the Company upon conversion request from the Bond Holders and also all other related matter with FCCBs. (3) To take the approval of the Shareholders of the Company through postal ballot to amend Other Object Clause of Memorandum of Association of the Company by insertion of new Sub-clause 65 and 6613 Mar · Board meeting
Company had informed the Exchange regarding the board meeting to be held on March 06, 2007, inter alia, to consider and approve allotment of Foreign Currency Convertible Bonds (FCCBs). The Company has now informed the Exchange that "the Adjourned Board Meeting of Original Board Meeting held on Tuesday the 06th day of March, 2007 of Board of Directors of Wanbury Limited, will be held, on Wednesday the 14th day of March 2007".
Feb 2007
28 Feb · Board meeting
Inter alia, to consider and approve allotment of Foreign Currency Convertible Bonds (FCCBs).